Evaluation of Genotoxicity of SU-Eohyeol Pharmacopuncture Using an In Vitro Chromosome Aberration Test in Chinese Hamster Lung Cell
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study was conducted to evaluate the safety of SU-Eohyeol pharmacopuncture (SUEP) by assessing its potential to cause chromosomal abnormalities in Chinese hamster lung cells (CHL/IC). Methods: A dose-curve was conducted to determine the highest dose of SUEP. Doses of 10, 5, 2.5, 1.25, 0.625, and 0.313% were used, and no cytotoxicity or SUEP precipitation was observed. SUEP doses of 10, 5, and 2.5%, with positive and negative controls, were used in a chromosome aberration test. Results: In this study, the frequency of abnormal chromosomal cells in the SUEP group did not show a statistically significant difference from that of the negative control group in short-term treatments with and without metabolic activation and the continuous treatment without metabolic activation. Compared with the negative control group, the positive control group had a significantly higher frequency of cells with structural chromosomal abnormalities. This test’s results satisfied all conditions for determining the results. Conclusion: SUEP did not induce chromosomal aberrations under the conditions of this study. Other toxicity evaluations, safety studies in humans, and various clinical trials are required to evaluate the safety and efficacy of SUEP.
Abstract
Objectives: This study was conducted to evaluate the safety of SU-Eohyeol pharmacopuncture (SUEP) by assessing its potential to cause chromosomal abnormalities in Chinese hamster lung cells (CHL/IC). Methods: A dose-curve was conducted to determine the highest dose of SUEP. Doses of 10, 5, 2.5, 1.25, 0.625, and 0.313% were used, and no cytotoxicity or SUEP precipitation was observed. SUEP doses of 10, 5, and 2.5%, with positive and negative controls, were used in a chromosome aberration test. Results: In this study, the frequency of abnormal chromosomal cells in the SUEP group did not show a statistically significant difference from that of the negative control group in short-term treatments with and without metabolic activation and the continuous treatment without metabolic activation. Compared with the negative control group, the positive control group had a significantly higher frequency of cells with structural chromosomal abnormalities. This test’s results satisfied all conditions for determining the results. Conclusion: SUEP did not induce chromosomal aberrations under the conditions of this study. Other toxicity evaluations, safety studies in humans, and various clinical trials are required to evaluate the safety and efficacy of SUEP.
참고문헌 (25)
- Lee MY, "Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test", BMC Complement Altern Med, 14, pp.215~ (2014)
- Timoroğlu İ, "Assessment of the genotoxic effects of organophosphorus insecticides phorate and trichlorfon in human lymphocytes", Environ Toxicol, 29(5), pp.577~587 (2014)
- Yüzbaşioğlu D, "Clastogenicity of the fungicide afugan in cultured human lymphocytes", Mutat Res, 604(1-2), pp.53~59 (2006)
- Rama RP, "Genotoxicity testing, a regulatory requirement for drug discovery and development : impact of ICH guidelines", Indian J Pharmacol, 34(2), pp.86~89 (2002)
- Jung C, "A clinical study of immune pharmacopuncturology", pp.523~ (2011), Kyungrak Medical Publishing Co
- Korean Acupuncture and Moxibustion Medicine Society, "Acupuncture medicine", pp.932~ (2020), Hanmi Medical Publishing Co
- 성수현, "Current Status of Management on Pharmacopuncture in Korea through Introduction of an Accreditation System", Journal of Pharmacopuncture, 22(2), pp.75~82 (2019), 대한약침학회[DOI]
- Sang Ha Woo, "Single-dose and 4-week repeated dose Toxicity of Aconitum Sinomontanum Nakai Pharmacopuncture: An Experimental Study", Journal of Acupuncture Research, 38(1), pp.47~59 (2021), 대한침구의학회[DOI]
- Ren Y, "A strategy for the detection of quality fluctuation of a Chinese herbal injection based on chemical fingerprinting combined with biological fingerprinting", J Pharm Biomed Anal, 56(2), pp.436~442 (2011)
- Park JE, "A survey on Korean medicine doctor’s use of Herbal Acupuncture and recognition of its national health insurance coverage", master, pp.2018
- 윤정원, "중성어혈약침 치료에 대한 임상논문 고찰 - 국내학술지를 중심으로", 한방재활의학과학회지, 27(4), pp.75~84 (2017), 한방재활의학과학회
- Kirkland D, "Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity", Mutat Res, 584(1-2), pp.1~256 (2005)
- 구자승, "Sprague-Dawley 랫드를 이용한 소핵시험을 통한 SU어혈약침의 안전성 평가", Korean Journal of Acupuncture, 39(2), pp.54~62 (2022), 경락경혈학회
- 구자승, "SU어혈약침의 복귀돌연변이시험을 이용한 유전독성평가", 동의생리병리학회지, 36(4), pp.113~119 (2022), 한의병리학회
- Pessayre D, "Oxford textbook of clinical hepatology", pp.1261~1315 (1999), Oxford University Press
- "Good Laboratory Practice Regulation for Nonclinical Laboratory Studies (Notification No. 2018-93)" (2018)[URL]
- "ENV/MC/CHEM(98)17: OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring Number 1" (1998)[URL]
- 이동진, "Review of Cervi Cornu Parvum Pharmacopuncture in Korean Medicine", Journal of Pharmacopuncture, 16(2), pp.7~14 (2013), 대한약침학회[DOI]
- Lee YM, "Introduction to evidence based medicine", J Korean Soc Vasc Surg, 19(2), pp.212~219 (2003)
- 이보람, "Regulation and status of herbal medicine clinical trials in Korea: a narrative review", Integrative Medicine Research, 10(2), pp.1~8 (2021), 한국한의학연구원[DOI]
- "Herbal Medicine (Crude Drug) Formulation_Non-clinical Trial_Guideline (Complainant’s Guideline)" (2017)[URL]
- Kim JH, "Recent trend of international guidelines for genotoxicity testing", Regul Res Food Drug Cosmet, 11(2), pp.201~209 (2016)
- 고연석, "〈方藥合編〉에 사용된 약물의 독성에 관한 문헌적 고찰", 동의생리병리학회지, 19(5), pp.1120~1128 (2005), 한의병리학회
- 이영준, "간, 신장수치 이상 환자에 附子 배합 처방 투여가 미치는 영향", 대한한의학 방제학회지, 19(2), pp.179~189 (2011), 대한한의학방제학회
- 박영철, "독성학적 측면에서의 한약에 의한 간독성 유발과 기전", 대한한의학회지, 32(4), pp.48~67 (2011), 대한한의학회
